PharmacyCodes



Dow-Isoniazid en es it fr

Dow-Isoniazid Brand names, Dow-Isoniazid Analogs

Dow-Isoniazid Brand Names Mixture

  • No information avaliable

Dow-Isoniazid Chemical_Formula

C19H24N2O3

Dow-Isoniazid RX_link

http://www.rxlist.com/cgi/generic2/labet.htm

Dow-Isoniazid fda sheet

Dow-Isoniazid FDA

Dow-Isoniazid msds (material safety sheet)

Dow-Isoniazid MSDS

Dow-Isoniazid Synthesis Reference

No information avaliable

Dow-Isoniazid Molecular Weight

328.406 g/mol

Dow-Isoniazid Melting Point

195-196 oC

Dow-Isoniazid H2O Solubility

20 mg/ml (HCl salt)

Dow-Isoniazid State

Solid

Dow-Isoniazid LogP

2.868

Dow-Isoniazid Dosage Forms

Liquid; Tablet

Dow-Isoniazid Indication

For the management of hypertension.

Dow-Isoniazid Pharmacology

Labetalol is an alpha-1 and beta adrenergic blocker used to treat high blood pressure. It works by blocking these adrenergic receptors, which slows sinus heart rate, decreases peripheral vascular resistance, and decreases cardiac output.

Dow-Isoniazid Absorption

Completely absorbed (100%) from the gastrointestinal tract with peak plasma levels occurring 1 to 2 hours after oral administration. The absolute bioavailability of labetalol is increased when administered with food.

Dow-Isoniazid side effects and Toxicity

LD50 = 66 mg/kg (Rat, IV). Side effects or adverse reactions include dizziness when standing up, very low blood pressure, severely slow heartbeat, weakness, diminished sexual function, fatigue

Dow-Isoniazid Patient Information

Dow-Isoniazid Organisms Affected

Humans and other mammals